EMEA-002577-PIP01-19
Key facts
| Active substance |
Gallium 68-labelled Prostate-Specific Membrane Antigen-11 (68Ga-PSMA-11)
|
| Therapeutic area |
|
| Decision number |
P/0290/2019
|
| PIP number |
EMEA-002577-PIP01-19
|
| Pharmaceutical form(s) |
Solution for injection/infusion
|
| Condition(s) / indication(s) |
Visualisation of prostate specific membrane antigen in prostate cancer
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Endocyte, Inc.
E-mail: cjordan@endocyte.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|